Walleye Capital
RDY icon

Walleye Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Walleye Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-41,500
Closed -$609K – 5929
2024
Q1 		$609K Buy
+41,500
New +$606K ﹤0.01% 3027

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's RDY Position: Q2 2024 in Review

Walleye Capital sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 97,310 shares — an estimated $1.43M sold.

Walleye Capital first reported a position in RDY in Q3 2023 and held it in 3 quarters. The position peaked at $7.43M in Q3 2023. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Walleye Capital reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • Walleye Capital sold 97,310 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $1.43M.
  • Walleye Capital first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 3 quarters.
  • Walleye Capital's Dr. Reddy's Laboratories position peaked at $7.43M in Q3 2023.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.